Pharma Foods International Co., Ltd.

Tokyo Stock Exchange 2929.T

Pharma Foods International Co., Ltd. Net Income for the year ending July 31, 2024: USD 21.38 M

Pharma Foods International Co., Ltd. Net Income is USD 21.38 M for the year ending July 31, 2024, a -1.26% change year over year. Net income is the total profit earned by a company after deducting all expenses, including taxes and non-controlling interest.

Pharma Foods International Co., Ltd. Net Income for the year ending July 31, 2023 was USD 21.65 M, a 871.43% change year over year.
Pharma Foods International Co., Ltd. Net Income for the year ending July 31, 2022 was USD -2.81 M, a -108.02% change year over year.
Pharma Foods International Co., Ltd. Net Income for the year ending July 31, 2021 was USD 35.01 M, a 437.62% change year over year.
Pharma Foods International Co., Ltd. Net Income for the year ending July 31, 2020 was USD 6.51 M, a 41.77% change year over year.

Key data

Date	Net Income	EPS (Diluted)	Shares (Diluted, Weighted)	Net Income Margin

Tokyo Stock Exchange: 2929.T

Pharma Foods International Co., Ltd.

CEO	Mr. Mu Jo Kim
IPO Date	June 12, 2006
Location	Japan
Headquarters	1-49 Goryo-Ohara
Employees	642
Sector	Health Care
Industries Pharmaceuticals Biotechnology Consumer Packaged Goods

Description

Pharma Foods International Co., Ltd. engages in the development and sale of functional food ingredients in Japan. Its products include Pharma-GABA, Bonepep, Ovopron (egg yolk globulin), Delicious Catechin, RunPep, and enriched Folic Acid Egg, as well as iHA, a substance that stimulates secretion of hyaluronic acid. Pharma Foods International Co., Ltd. has licensing agreement with Mitsubishi Tanabe Pharma Corporation for a new therapeutic antibody to treat autoimmune diseases. Pharma Foods International Co., Ltd. was founded in 1997 and is based in Kyoto, Japan.

Key trends

Past 5 years